Evidence map›Paper›PMID 31197039›Full record

ArticleThe Journal of biological chemistry2019

Bicarbonate is essential for protein-tyrosine phosphatase 1B (PTP1B) oxidation and cellular signaling through EGF-triggered phosphorylation cascades.

Markus Dagnell, Qing Cheng, Syed Husain Mustafa Rizvi, Paul E Pace, Benoit Boivin, Christine C Winterbourn, Elias S J Arnér

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Ten "Cheat Codes" for Measuring Oxidative Stress in Humans.Antioxidants (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Biological and Catalytic Properties of Selenoproteins.International journal of molecular sciences · 2023
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Markus DagnellDivision of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 77, Stockholm, Sweden. Electronic address: Markus.Dagnell@ki.se.
Qing ChengDivision of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
Syed Husain Mustafa RizviDepartment of Nanobioscience, SUNY Polytechnic Institute, Albany, New York 12203.
Paul E PaceCentre for Free Radical Research, Department of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand.
Benoit BoivinDepartment of Nanobioscience, SUNY Polytechnic Institute, Albany, New York 12203.
Christine C WinterbournCentre for Free Radical Research, Department of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand. Electronic address: Christine.Winterbourn@otago.ac.nz.
Elias S J ArnérDivision of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 77, Stockholm, Sweden. Electronic address: Elias.Arner@ki.se.
Karolinska Institutet · SESUNY Polytechnic Institute · USUniversity of Otago · NZ

Funding

Role of the Phosphoprotein Phosphatase PTP1B in Cardiac HypertrophyR15HL138605 · NHLBI · SUNY POLYTECHNIC INSTITUTE · PI BOIVIN, BENOIT · 2017 to 2020
$896k
NHLBI NIH HHS R15 HL138605
6 · The paper itself

Abstract

Protein-tyrosine phosphatases (PTPs) counteract protein tyrosine phosphorylation and cooperate with receptor-tyrosine kinases in the regulation of cell signaling. PTPs need to undergo oxidative inhibition for activation of cellular cascades of protein-tyrosine kinase phosphorylation following growth factor stimulation. It has remained enigmatic how such oxidation can occur in the presence of potent cellular reducing systems. Here, using

Indexed as

Acid-Base EquilibriumBicarbonatesCell Line, TumorEpidermal Growth FactorHomeodomain ProteinsHumansHydrogen PeroxideNADPOxidation-ReductionPhosphorylationProtein Tyrosine Phosphatase, Non-Receptor Type 1Signal TransductionThioredoxin Reductase 1ThioredoxinsBicarbonatesEpidermal Growth FactorHomeodomain ProteinsHydrogen PeroxideNADPProtein Tyrosine Phosphatase, Non-Receptor Type 1PRRX2 protein, humanPTPN1 protein, humanThioredoxin Reductase 1ThioredoxinsTXNRD1 protein, humanbicarbonateepidermal growth factor receptor (EGFR)oxidative inactivationperoxiredoxinperoxymonocarbonatephosphatasephosphorylation cascadeprotein-tyrosine phosphatase (PTP)redox regulationredox signalingthioredoxin reductase

Identifiers

PMID31197039
PMCPMC6699834
OpenAlexW2952982210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.